Feedbacks and adaptive capabilities of the PI3K/Akt/mTOR axis in acute myeloid leukemia revealed by pathway selective inhibition and phosphoproteome analysis-Reference-Cited by-同舟云学术

Feedbacks and adaptive capabilities of the PI3K/Akt/mTOR axis in acute myeloid leukemia revealed by pathway selective inhibition and phosphoproteome analysis

Published:2014-04-04 Issue:11 Volume:28 Page:2197-2205
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Bertacchini J,Guida M,Accordi B,Mediani L,Martelli A M,Barozzi P,Petricoin E,Liotta L,Milani G,Giordan M,Luppi M,Forghieri F,De Pol A,Cocco L,Basso G,Marmiroli S

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu2014123.pdf

Reference53 articles.

1. Theilgaard-Mönch K, Boultwood J, Ferrari S, Giannopoulos K, Hernandez-Rivas JM et al. Gene expression profiling in MDS and AML: potential and future avenues. Leukemia 2011; 25: 909–920.

2. Ferrara F, Schiffer CA . Acute myeloid leukaemia in adults. Lancet 2013; 9: 484–495.

3. Leung AY, Man CH, Kwong YL . FLT3 inhibition: a moving and evolving target in acute myeloid leukaemia. Leukemia 2013; 27: 260–268.

4. Bai Y, Bandara G, Ching Chan E, Maric I, Simakova O, Bandara SN et al. Targeting the KIT activating switch control pocket: a novel mechanism to inhibit neoplastic mast cell proliferation and mast cell activation. Leukemia 2013; 27: 278–285.

5. Doepfner KT, Boller D, Arcaro A . Targeting receptor tyrosine kinase signaling in acute myeloid leukemia. Crit Rev Oncol Hematol 2007; 3: 215–230.

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Caspase-2 is essential for proliferation and self-renewal of nucleophosmin-mutated acute myeloid leukemia;Science Advances;2024-08-02

2. Identification of triciribine as a novel myeloid cell differentiation inducer;PLOS ONE;2024-05-14

3. Everolimus and mycophenolate mofetil effectively prevent GvHD in children with severe acute kidney injury undergoing allogeneic HSCT;2024-03-16

4. Development of Proteomics and Its Use in Acute Myeloid Leukemia;Advances in Clinical Medicine;2024

5. Anti-leukemia effects of omipalisib in acute myeloid leukemia: inhibition of PI3K/AKT/mTOR signaling and suppression of mitochondrial biogenesis;Cancer Gene Therapy;2023-10-11